2025 ICD-10 CM DIAGNOSIS INDEX TERMS STARTING WITH Z

Genetic susceptibility to malignant neoplasm - Z15.0
Genetic susceptibility to malignant neoplasm of breast - Z15.01
Genetic susceptibility to malignant neoplasm of ovary - Z15.02
Genetic susceptibility to malignant neoplasm of prostate - Z15.03
Genetic susceptibility to malignant neoplasm of endometrium - Z15.04
Genetic susceptibility to other malignant neoplasm - Z15.09
Genetic susceptibility to epilepsy and neurodevelopmental disorders - Z15.1
Genetic susceptibility to obesity - Z15.2
Genetic susceptibility to other disease - Z15.8
Genetic susceptibility to multiple endocrine neoplasia [MEN] - Z15.81
Genetic susceptibility to other disease - Z15.89
Resistance to beta lactam antibiotics - Z16.1
Resistance to unspecified beta lactam antibiotics - Z16.10
Resistance to penicillins - Z16.11
Extended spectrum beta lactamase (ESBL) resistance - Z16.12
Resistance to carbapenem - Z16.13
Resistance to other specified beta lactam antibiotics - Z16.19
Resistance to other antibiotics - Z16.2
Resistance to unspecified antibiotic - Z16.20
Resistance to vancomycin - Z16.21
Resistance to vancomycin related antibiotics - Z16.22
Resistance to quinolones and fluoroquinolones - Z16.23
Resistance to multiple antibiotics - Z16.24
Resistance to other single specified antibiotic - Z16.29
Resistance to other antimicrobial drugs - Z16.3
Resistance to unspecified antimicrobial drugs - Z16.30
Resistance to antiparasitic drug(s) - Z16.31
Resistance to antifungal drug(s) - Z16.32
Resistance to antiviral drug(s) - Z16.33
Resistance to antimycobacterial drug(s) - Z16.34
Resistance to single antimycobacterial drug - Z16.341
Resistance to multiple antimycobacterial drugs - Z16.342
Resistance to multiple antimicrobial drugs - Z16.35
Resistance to other specified antimicrobial drug - Z16.39
Estrogen receptor positive status [ER+] - Z17.0
Estrogen receptor negative status [ER-] - Z17.1
Progesterone receptor status - Z17.2
Progesterone receptor positive status - Z17.21
Progesterone receptor negative status - Z17.22
Human epidermal growth factor 2 receptor - Z17.3
Human epidermal growth factor receptor 2 positive status - Z17.31
Human epidermal growth factor receptor 2 negative status - Z17.32
Combined receptor status - Z17.4
Hormone receptor positive - Z17.41
Hormone receptor positive with human epidermal growth factor receptor 2 positive status - Z17.410
Hormone receptor positive with human epidermal growth factor receptor 2 negative status - Z17.411
Hormone receptor negative - Z17.42
Hormone receptor negative with human epidermal growth factor receptor 2 positive status - Z17.420
Hormone receptor negative with human epidermal growth factor receptor 2 negative status - Z17.421
Retained radioactive fragments - Z18.0
Retained depleted uranium fragments - Z18.01
Other retained radioactive fragments - Z18.09
Retained metal fragments - Z18.1
Retained metal fragments, unspecified - Z18.10
Retained magnetic metal fragments - Z18.11
Retained nonmagnetic metal fragments - Z18.12
Retained plastic fragments - Z18.2
Retained organic fragments - Z18.3
Retained animal quills or spines - Z18.31
Retained tooth - Z18.32
Retained wood fragments - Z18.33
Other retained organic fragments - Z18.39
Other specified retained foreign body - Z18.8
Retained glass fragments - Z18.81
Retained stone or crystalline fragments - Z18.83
Other specified retained foreign body fragments - Z18.89
Retained foreign body fragments, unspecified material - Z18.9
Hormone sensitive malignancy status - Z19.1
Hormone resistant malignancy status - Z19.2
Contact with and (suspected) exposure to intestinal infectious diseases - Z20.0
Contact with and (suspected) exposure to intestinal infectious diseases due to Escherichia coli (E. coli) - Z20.01
Contact with and (suspected) exposure to other intestinal infectious diseases - Z20.09
Contact with and (suspected) exposure to tuberculosis - Z20.1
Contact with and (suspected) exposure to infections with a predominantly sexual mode of transmission - Z20.2
Contact with and (suspected) exposure to rabies - Z20.3
Contact with and (suspected) exposure to rubella - Z20.4
Contact with and (suspected) exposure to viral hepatitis - Z20.5
Contact with and (suspected) exposure to human immunodeficiency virus [HIV] - Z20.6
Contact with and (suspected) exposure to pediculosis, acariasis and other infestations - Z20.7
Contact with and (suspected) exposure to other communicable diseases - Z20.8
Contact with and (suspected) exposure to other bacterial communicable diseases - Z20.81
Contact with and (suspected) exposure to anthrax - Z20.810
Contact with and (suspected) exposure to meningococcus - Z20.811
Contact with and (suspected) exposure to other bacterial communicable diseases - Z20.818
Contact with and (suspected) exposure to other viral communicable diseases - Z20.82
Contact with and (suspected) exposure to varicella - Z20.820
Contact with and (suspected) exposure to Zika virus - Z20.821
Contact with and (suspected) exposure to COVID-19 - Z20.822
Contact with and (suspected) exposure to other viral communicable diseases - Z20.828
Contact with and (suspected) exposure to other communicable diseases - Z20.89
Contact with and (suspected) exposure to unspecified communicable disease - Z20.9
Carrier of typhoid - Z22.0
Carrier of other intestinal infectious diseases - Z22.1
Carrier of diphtheria - Z22.2
Carrier of other specified bacterial diseases - Z22.3
Carrier of bacterial disease due to meningococci - Z22.31
Carrier of bacterial disease due to staphylococci - Z22.32
Carrier or suspected carrier of Methicillin susceptible Staphylococcus aureus - Z22.321
Carrier or suspected carrier of Methicillin resistant Staphylococcus aureus - Z22.322
Carrier of bacterial disease due to streptococci - Z22.33

« Previous
1
2
3
4
5
6
7
…
17
18
Next »